Evidence map›Paper›PMID 38055306›Full record

ReviewGut microbes2023

Samuel J Gavzy, Allison Kensiski, Zachariah L Lee, Emmanuel F Mongodin, Bing Ma, Jonathan S Bromberg

Open access · goldAbstract readReview
In one paragraph

Review in Gut microbes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 190 papers.

0numbers the graph read from it
0cells of the map it votes in
190citing papers in PubMed
37.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

190 citing papers in PubMed, 246 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Efficacy ofFrontiers in nutrition · 2026
    Trial
  6. Trial
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Intestinal-Bone Axis Mediated byMicroorganisms · 2026
    Review
  13. Article
  14. Review
  15. Article
  16. The long-lived immune system of centenarians.Nature reviews. Immunology · 2026
    Review
  17. Review
  18. Fucoidan Derived fromAnimals : an open access journal from MDPI · 2026
    Article
  19. Article
  20. Review

130 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Samuel J GavzyCenter for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD, USA.
Allison KensiskiCenter for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD, USA.
Zachariah L LeeCenter for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD, USA.
Emmanuel F MongodinInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
Bing MaInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
Jonathan S BrombergCenter for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD, USA.
University of Maryland, Baltimore · US

Funding

QAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7M
Signaling Pathways in Innate ImmunityT32AI095190 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Stefanie N. Vogel · 2012 to 2026
$4.7M
Immunological and functional consequences triggered by the gut microbiota regulate alloimmunity and cardiac transplant outcomeR01HL148672 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BROMBERG, JONATHAN S, MA, BING · 2019 to 2022
$2.3M
Mechanisms of microbiome-driven cardiac allograft outcomesU01AI170050 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Jonathan S Bromberg, Bing Ma · 2022 to 2026
$1.9M
NCATS NIH HHS UL1 TR003098NHLBI NIH HHS R01 HL148672NIAID NIH HHS T32 AI095190NIAID NIH HHS U01 AI170050
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gastrointestinal MicrobiomeBifidobacteriumHomeostasisHumansImmune ToleranceImmunomodulationBifidobacteriagut microbiomeimmune homeostasislive biotherapeuticsmetabolitestolerogenic immune responses

Identifiers

PMID38055306
PMCPMC10730214
OpenAlexW4389365755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.